Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Yasmine Derradji"'
Autor:
Yasmine Derradji, Agata Mosinska, Stefanos Apostolopoulos, Carlos Ciller, Sandro De Zanet, Irmela Mantel
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-11 (2021)
Abstract Age-related macular degeneration (AMD) is a progressive retinal disease, causing vision loss. A more detailed characterization of its atrophic form became possible thanks to the introduction of Optical Coherence Tomography (OCT). However, ma
Externí odkaz:
https://doaj.org/article/99cc5b247c774ecc9830aa9e194367de
Autor:
Irmela Mantel, Angelica Borgo, Jacopo Guidotti, Edwige Forestier, Olga Kirsch, Yasmine Derradji, Patrice Waridel, Frédéric Burdet, Florence Mehl, Claude Schweizer, Raphaël Roduit
Publikováno v:
Frontiers in Pharmacology, Vol 11 (2020)
The standard treatment for neovascular age-related macular degeneration (nAMD) consists of intravitreal anti-vascular endothelial growth factors (VEGF). However, for some patients, even maximal anti-VEGF treatment does not entirely suppress exudative
Externí odkaz:
https://doaj.org/article/7ead8016a29e4649b123e3ccd7a662f0
Publikováno v:
Klinische Monatsblatter fur Augenheilkunde. 239(4)
Autor:
Andrea Montesel, Sandro De Zanet, Agata Mosinska, Yasmine Derradji, Stefanos Apostolopoulos, Carlos Ciller, Irmela Mantel, Anthony Gigon
Publikováno v:
Translational vision science & technology, vol. 10, no. 13, pp. 18
Translational Vision Science & Technology
Translational Vision Science & Technology
Purpose To develop and validate an automatic retinal pigment epithelial and outer retinal atrophy (RORA) progression prediction model for nonexudative age-related macular degeneration (AMD) cases in optical coherence tomography (OCT) scans. Methods L
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4a179b7104e8dfb0647c3223f2ae2698
https://serval.unil.ch/notice/serval:BIB_58D22BF25735
https://serval.unil.ch/notice/serval:BIB_58D22BF25735
Autor:
Raphaël Roduit, Florence Mehl, Yasmine Derradji, Irmela Mantel, Claude Schweizer, Angelica Borgo, Edwige Forestier, Jacopo Guidotti, Olga Kirsch, Frédéric Burdet, Patrice Waridel
Publikováno v:
Frontiers in Pharmacology
Frontiers in pharmacology, vol. 11, pp. 594087
Frontiers in Pharmacology, Vol 11 (2020)
Frontiers in pharmacology, vol. 11, pp. 594087
Frontiers in Pharmacology, Vol 11 (2020)
The standard treatment for neovascular age-related macular degeneration (nAMD) consists of intravitreal anti-vascular endothelial growth factors (VEGF). However, for some patients, even maximal anti-VEGF treatment does not entirely suppress exudative